FDA Expedites Review of Psychedelic Drugs for Mental Health Treatment

FDA Grants Quick Review Psychedelic Drugs, First Approvals Could Come As Soon As Summer

FDA Grants Quick Review Psychedelic Drugs, First Approvals Could Come As Soon As Summer The FDA announced new steps to speed up research on psychedelic treatments for serious mental health conditions, following an executive order from President Donald Trump directing agencies to expand access to emerging therapies, CNBC and NBC reported this morning: In a press release Friday, FDA commissioner Marty Makary said the medications “have the potential to address the nation’s mental h...

By Tyler Durden